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Lovastatin is a well-known natural statin, which is used for lowering plasma cholesterol
levels by inhibiting 3-hydroxy-3-methyl glutaryl coenzyme A reductase. Different strains of
Aspergillus and Monascus sp. have been exploited for statin production but Monascus san-
guineus is still unexplored. In this study, lovastatin production from Monascus sanguineus
under solid state fermentation was optimized using response surface methodology. The
optimized value of the lovastatin yield was 20.04 mg/gds with soybean concentration of
20 g/L, CaCl2 concentration of 2.5 g/L, acetic acid concentration of 25 mL and inoculum size
of 3.4 mL. This study also documented spectrometric characterization and fragment
pattern of lovastatin with the help of Fourier transfer infrared spectrometry and mass
spectrometry. Citrinin was not detected in any of the samples used for this study.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Coronary heart disease and most heart attacks are due to
hypercholesterolemia, which is the accumulation of choles-
terol in blood plasma that results in atherosclerosis (blockage
of arteries). Almost one-third of the total body cholesterol
comes from food intake and the other two-thirds is syn-
thesised in the body [1]. A potent hypocholesterolemic agent,
known as lovastatin (mevinolin and monacolin K) can inhibit
the rate-limiting enzyme 3-hydroxy-3-methyl glutaryl coen-
zyme A reductase. This enzyme has a regulatory and rate-obiology, Centre for PG S
vam2010tpraviju@gmail.c
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).limiting function in cholesterol biosynthesis [2]. Lovastatin
was the first natural statin; it is a fungal secondarymetabolite
and was approved by the US Food and Drug Administration in
August 1987 [3,4]. The microorganisms used for statin pro-
duction under solid-state fermentation (SSF) conditions
mostly belong to Aspergillus andMonascus sp. There are also a
few reports of statin production in rice fermented by Penicil-
lium andMonascus sp., which is also called Angkak. It is known
to contain several valuable secondary metabolites such as
lovastatin, g-aminobutyric acids, monascodilone, monascor-
ubramine, monascin, ankaflavin, rubropunctatin and citrinin
[5e7].tudies, Jain University, 18/3, 9th Main road, 3rd Block, Jayanagar,
om (P. Tallapragada).
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carcinogenic activities. Penicillium citrinum, Aspergillus sp. and
Monascus sp. along with other secondary metabolites are
known to produce citrinin, which greatly limits the applica-
tion of the Monascus fermented products. Due to a potential
risk to livestock and human health, extensive research on
citrinin biosynthesis is being conducted. Comprehensive de-
tails are not known about the biological background of citrinin
biosynthesis [8].
Recent studies have mainly focused on the production of
microbial secondary metabolites using SSF approaches. The
development of good-quality fermenters along with tem-
perature, humidity, aeration, and sterility control has accel-
erated research using SSF. However, research should also
explore new strains for improved statin production [9]. Mass
spectrometry (MS) with electrospray ionization is considered
an expanding approach for the structural elucidation of
organic species. It can provide molecular mass information
along with fragment pattern. It is widely used for the iden-
tification of impurities and depredates in the pharmaceutical
industry [10].
Response surfacemethodology (RSM) can be used to assess
the relative significance of several affecting factors. It is an
empirical statistical modeling technique used for multiple
regression analysis using quantitative data. These data are
obtained from appropriately designed experiments required
to solvemultivariable equations simultaneously. RSM is being
increasingly used for optimization of the process in fermen-
tation [11].
The purpose of present study was to determine suitable
conditions for scale-up of lovastatin production, verification
of the absence of citrinin, and spectrometric characterization
of lovastatin. The experiments were carried out under SSF
withMonascus sanguineus in order to achieve optimumSI yield.
Characterization of lovastatin was done with UV spectro-
photometry and Fourier transform infrared (FT-IR) tech-
niques. Liquid chromatography (LC)-MS was used to study
fragment ions and mass using an electrospray ionization
approach.2. Methods
2.1. Culture and inoculum preparation
Pomegranate (Punica granatum) was used to isolate the wild
strain of Monascus, which was identified as M. sanguineus.
The spores were scraped off under aseptic conditions to
produce a spore suspension that was prepared in 0.9% saline
water [12].Table 1 e Four variables in coded and natural units.
Variables with
designate
Code Actual factor level at
coded factor levels of
2 1 0 1 2
Soybean meal (g/L) X1 4 8 12 16 20
CaCl2 (g/L) X2 0.5 1 1.5 2 2.5
Acetic acid %(v/v) X3 0 0.025 0.05 0.075 0.1
Inoculum size % (v/v) X4 5 8 11 14 172.2. SSF
Ten grams of wheat bran as a substrate were taken
and placed in a 250-mL conical flask to which 30 mL of
basal medium was added. The basal medium composition
included 100 g dextrose, 10 g peptone, 2 g KNO3, 2 g NH4 H2
PO4, 0.5 g MgSO4.7H2O, and 0.1 g in 1 L distilled water. The
pH of the medium was adjusted to 6.0 [13].2.3. Extraction of lovastatin
Acetonitrile was used as extraction solvent. One gram of fer-
mented dry substrate was dissolved in 20 mL acetonitrile and
kept ina shaker incubator for 2hoursat 180 rpmand70C. Itwas
then filtered with Whatman filter paper (Sigma Aldrich, USA)
and the filtrate was centrifuged at 3000  g for 8 minutes [14].
2.4. Screening of citrinin
Fermented dry substrates were dissolved in ethyl acetate and
acetified up to pH 5. The aqueous layer was removed and the
organic layer was concentrated. Ten microliters of these
samples was applied to Silica gel 60 F254 Aluminum sheets
(Merck, Germany). Ethyl acetate: acetone: water (4: 4: 1, by
volume) was used as the mobile phase. Subsequently, the
drying plates were examined under UV light at 350 nm to
observe fluorescent yellow bands [15].
2.5. Estimation of lovastatin by UV spectrophotometry
Lovastatin was purified from the sample with the help of thin
layer chromatography (TLC). Purified spots from TLC were
scraped and transferred into glass tubes and acetonitrile was
added. The tubeswere centrifuged, filtered, and the filtrate was
estimated at 238 nm using UV-visible spectrophotometry.
Lovastatinwasestimated in its acid form (mevinolinic acid) [16].
2.6. Identification of lovastatin by FT-IR and LC-MS
For FT-IR analysis, the samplewas kept in vacuumdesiccators
over solid KOH for 48 hours and IR analysis was carried out
using Thermo-Nicolet 6700 Fourier Transfer Infrared spec-
trometer. LC-MS analysis was carried using a
250 mm  4.6 mm internal diameter Lichrosper 100 C18 col-
umn of particle size 5 mm, loop injector of 20 mL, and Shimadzu
CLASS-VP version 5.032 software (Shimadzu, Japan). The
mobile phase used for this analysiswas acetonitrile: water (65:
35 v/v and pH 3.5). The flow rate was set to 1.0 mL/min and the
detection was carried out using a wavelength of 235 nm by UV
detector SPD10A VP (Shimadzu Europe, Germany) [17].
2.7. Experimental design (RSM)
The experimental design was formulated according to the
central composite design of RSM using MATLAB software for
four selected parameters: soya bean meal, CaCl2, acetic acid
and inoculum size (Table 1). A set of 30 experiments was
required with each variable being at five levels. All the flasks
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values and actual values, independent variable and the
response were calculated according to the second-order
quadratic model (Table 2). The relative effects of two vari-
ables on responsewere examined from the three-dimensional
surface and contour plots. MATLAB version 7.5.0.342 (R2007b)
from Math Works, USA was used for the regression and
graphical analysis of the experimented data and for analyzing
the response surface and contour plots. Analysis of variance
was used to estimate the statistical parameters with a sig-
nificance level of p < 0.001 [18].3. Results and discussion
3.1. Verification of absence of citrinin
TLC revealed thatM. sanguineus strain did not produce citrinin
in the present experimental conditions, although citrinin was
detected in our earlier study using potato dextrose broth [12].
You et al [19] have also reported a lower amount of citrinin
produced by M. sanguineus compared to other Monascus spe-
cies. The reported concentration was 386 mg/L, 120 mg/L and
78 mg/L for Monascus purpureus, Monascus ruber and M. san-
guineus, respectively. There is a possibility of citrinin amountTable 2 e Full factorial central composite design of four variab
responses.
Run No. Soybean g/L CaCl2 g/L Acetic acid (mL)
1. 8 1 10
2. 16 1 10
3. 8 2 10
4. 16 2 10
5. 8 1 20
6. 16 1 20
7. 8 2 20
8. 16 2 20
9. 8 1 10
10. 16 1 10
11. 8 2 10
12. 16 2 10
13. 8 1 20
14. 16 1 20
15. 8 2 20
16. 16 2 20
17. 4 1.5 15
18. 20 1.5 15
19. 12 0.5 15
20. 12 2.5 15
21. 12 1.5 0
22. 12 1.5 25
23. 12 1.5 15
24. 12 1.5 15
25. 12 1.5 15
26. 12 1.5 15
27. 12 1.5 15
28. 12 1.5 15
29. 12 1.5 15
30. 12 1.5 15
All experiments were carried in duplicate; the above-mentioned values abeing diminutive enough to be detected by TLC. The concen-
tration of optimized nutrients (acetic acid, CaCl2 and soybean)
would have provided a physiological balance between organ-
ism growth and lovastatin yield from M. sanguineus and
inhibited citrinin production. Sani et al [20] have reported a
reduction in citrinin concentration and enhanced yield of
lovastatin by M. purpureus in SSF conditions. The optimized
conditions were 2% (v/w) glycerol, 0.14% (w/w) methionine,
and 0.01% (w/w) NaNO3 at 25C for 16 days. The fungus yielded
monacolin K and citrinin of 5900 mg/kg substrate dry weight
(sdw) and 0.26 mg/kg sdw, respectively.
3.2. Optimization of lovastatin
The quadratic polynomial explaining the relationship of the
four variables for lovastatin yield is given below
Y ¼ b0 þ b1X1 þ b2X2 þ b3X3 þ b4X4 þ b5X1X2 þ b6X1X3
þ b7X1X4 þ b8X2X3 þ b9X2X4 þ b10X3X4 þ b11X21 þ b12X22
þ b13X23 þ b14X24 (1)
Where Y is the response of the quadratic model (lovastatin
yield), bi (i¼ 0e14) are the regression coefficients and X1, X2, X3
and X4 are the coded independent factors (Table 1). Applying
the regression analysis, equation (1) can be rewritten as
below:les in coded and natural units along with the observed
Inoculum size (mL) Lovastatin (mg/gds)
Experimental Predicted
1.6 6.75 6.72
1.6 4.20 4.06
1.6 3.45 3.56
1.6 4.80 4.54
1.6 7.65 7.75
1.6 5.70 6.00
1.6 5.10 5.48
1.6 6.90 7.36
2.8 5.73 5.14
2.8 3.90 3.55
2.8 5.10 4.83
2.8 7.10 6.87
2.8 6.60 6.89
2.8 6.45 6.21
2.8 7.26 7.46
2.8 5.70 5.58
2.2 5.40 5.59
2.2 6.18 5.98
2.2 4.20 4.48
2.2 5.70 5.52
2.2 5.10 5.54
2.2 10.50 9.60
1 6.24 5.73
3.4 6.60 7.21
2.2 5.88 5.98
2.2 5.76 5.98
2.2 5.82 5.98
2.2 5.64 5.98
2.2 5.49 5.98
2.2 6.60 5.98
re mean values.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 4 3 3e4 4 0436lovastatin yieldðmg=gdsÞ ¼ 26:3668 0:8767X1  8:5303X2
 0:5716X3  6:6755X4
þ 0:4544X1X2 þ 0:0114X1X3
þ 0:0114X1X4 þ 2:3688X2X4
 0:9783X22 þ 0:0133X23
(2)
The influence of the individual independent variable,
keeping other variables at their central level, is shown in the
subplots of Fig. 1. The trend for the lovastatin yieldwas similar
for acetic acid, inoculum size and soybean meal, which
initially showed a reduction in the yield. The yield increased
subsequently with the increase in the values of the above-
mentioned parameters. The relationship between the lova-
statin yield and CaCl2 concentration was almost linear with
the yield increasing steadily.
The interactive effects of CaCl2 and soybean concentra-
tion on lovastatin yield showed an interesting trend (first
subplot of Fig. 2). Keeping one variable at a lower level and
increasing the others resulted in a decrease in lovastatin
yield. Hence, the maximum yield was obtained with both
the variables at their maximum (lovastatin yield of 7.83 mg/
gds with CaCl2 concentration of 2.5 g/L and soybean con-
centration of 20 g/L) or minimum (lovastatin yield of
7.38 mg/gds with CaCl2 concentration of 0.5 g/L and soy-
bean concentration of 4 g/L) levels. This predominant
behavior can be correlated with the high t value obtained
for the interaction of CaCl2 and soybean (Table 3). A similar
trend, though smaller, was noticed for the interactive ef-
fects of inoculum size and CaCl2 concentration (data not
shown).Fig. 1 e Response of the model depictinThe effect of the concentration of acetic acid and soybean
meal showed a valley-type trend, with almost no variation
with the increase in the concentration of soybean. The lova-
statin yield increased in a parabolic way with the increase in
concentration of acetic acid. The maximum value of the
lovastatin yield was ~10.12 mg/gds with acetic acid concen-
tration of 25 mL and soybean concentration of 20 g/L (second
subplot of Fig. 2).
Inoculum size and soybean concentration showed slight
variation with the change in the values of the variables. The
peaks were obtained with either the maximum values of the
variables or with their minimum values. The above observa-
tion is also endorsed by the insignificant p value obtained for
the interaction effect of these two variables (Table 3). The
maximum value of lovastatin yield was ~6.99 mg/gds with
inoculum size of 3.4 mL and soybean concentration of 20 g/L
(third subplot of Fig. 2).
The lovastatin yield dependency on the concentration of
acetic acid and CaCl2 also showed a valley-type trend, with
almost no variation with the increase in concentration of
CaCl2. The lovastatin yield increased in a parabolic way with
the increase in concentration of acetic acid. The maximum
value of the lovastatin yield was ~10.1 mg/gds with acetic acid
concentration of 25 mL and CaCl2 concentration of 2.19 g/L
(fourth subplot of Fig. 2).
From the analysis of variance it can be seen that the model
represented by equation (1) was highly significant with a p
value of 0.00001. Also the R2 (determination coefficient) value
for the lovastatin yield was 0.9214, indicating that 92.14% of
the total variation in the observed response value could be
explained by the model, or by experimental parameters and
their interactions (Table 4). The coefficient estimated in theg influence of individual variables.
Fig. 2 e 3D Response surface and contour subplots showing the relative effect of tested variables.
Table 3 e Regression coefficient results from the data of
central composite designed experiments for lovastatin
yield.
Values Coefficients Standard
error
t
value
p
value
Constant 26.3668 4.8142 5.48 0.00006
Soybean meal (g/L) 0.8767 0.2943 2.98 0.00936
CaCl2 (g/L) 8.5303 2.1415 3.98 0.00120
Acetic acid %(v/v) 0.5716 0.1904 3.00 0.00894
Inoculum size % (v/v) 6.6755 1.8441 3.62 0.00252
Soybean meal  CaCl2 0.4544 0.0662 6.87 0.00001
Soybean meal 
acetic acid
0.0114 0.0066 1.72 0.10620
Soybean meal 
inoculum size
0.1114 0.0551 2.02 0.06149
CaCl2  acetic acid 0.0883 0.0551 1.60 0.13029
CaCl2  inoculum size 2.3688 0.4595 5.16 0.00012
Acetic acid 
inoculum size
0.0598 0.0459 1.30 0.21274
Soybean meal 
soybean meal
0.0084 0.0067 1.26 0.22813
CaCl2  CaCl2 0.9783 0.3962 2.47 0.02604
Acetic acid 
acetic acid
0.0133 0.0025 5.32 0.00009
Inoculum size 
inoculum size
0.3415 0.2751 1.24 0.23361
Table 4 e Analysis of variance for response surface quadratic
Sum of squares Degree of Freedom f value
3.99 14 12.56
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Table 3. The table shows that the linear effect of the acetic acid
concentration affected the yield most. This implies that the
acetic acid concentration played an important role in lova-
statin yield, because it can act as a carbon source and as a pH
regulator. The quadratic effects of acetic acid and soybean
meal were more significant than those of the other factors.
The interactive effects of CaCl2 with soybean meal and inoc-
ulum size were found to be more significant than the other
interactive effects.
Several attempts have been made for statin production
under SSF conditions. Complex and simple carbon sources
and several agro-industrial residues such as wheat bran,
bagasse, barley, soybeanmeal, gram bran and fruit waste, and
supplementation with organic and inorganic nitrogen and
mineral salts have been used to synthesize and optimize the
lovastatin yield. Among several types of agro-industrial waste
tested, wheat bran has emerged as themost suitable substrate
for lovastatin production by different microorganisms. Valera
et al [1] have reported lovastatin yield of 16.65 mg/gds with
Aspergillus flavipes BICC 5174 and wheat bran as substrates.
With the same substrate, Patil et al [21] have reported a
lovastatin yield of 12.5 mg/gds with Aspergillus terreus PM3. As
far asMonascus strains are concerned, few attempts have been
made to screen and optimize the lovastatin yield.M. purpureus
MTCC 369 along with rice supplemented with ammoniummodel.
p value Mean square R2 Adjusted R2
0.00001 0.27 0.9214 0.8480
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 4 3 3e4 4 0438chloride yielded 3.422 mg/gds [14]. Panda et al [22] have also
attempted to optimize the lovastatin yield (2.80 mg/gds) with
combination of M. purpureus MTCC 369 þ M. ruber MTCC 1880
and rice supplemented with malt extract and dextrose as
substrate. Xu et al [23] have reported a maximum yield of
lovastatin (4e6 mg/gds) from M. ruber when rice was supple-
mentedwith soybean powder, sucrose, yeast extract, glycerol,
sodium nitrate and acetic acid. They used one variable at a
time to optimize the yield.
The present study successfully established the optimum
conditions for lovastatin yield with wheat bran as substrate
and absence of citrinin. The cumulative effects of variables
such as soybean meal, inoculum size, and acetic acid and
CaCl2 concentrations were also explored and encouraging
results were obtained. Such a high yield of lovastatin with a
wild strain of M. sanguineus opens the door for further
research in this direction. The efficiency of this strain can
meet the requirements for the current demand for production
of natural statins.
3.3. Spectrometric analysis of lovastatin
Purified lovastatin from Monascus-fermented substrate had
maximum UV absorption near to 238 nm (Fig. 3 inset). Such
an absorption band corresponded to a pep* transition owing
to the conjugated double bonds. This compound was
analyzed with FT-IR and LC-MS. The FT-IR spectra of the
purified compound (Fig. 3) showed characteristic peaks at
3470.25 cm1 (non-hydrogen-bonded free OeH stretching
vibration also appeared to the left of this peak, indicating the
alcohol/phenolic group); 2260.69 cm1 (methyl and methy-
lene CeH asymmetric stretching); 2071.67 cm1 (weakFig. 3 e Fourier transform infrared spectra andovertone for the aromatic ring); 1645.23 cm1 (lactone and
ester carbonyl stretch without any cis or trans conforma-
tions); 1491.53 cm1 (band due to methylene scissoring and
methyl and methylene bending vibration); 1342.55 cm1
(weak peak for CeOeH bending vibrations); 850 cm1 (alcohol
CeOH stretch); 804.67 cm1 (strong peak for tri-substituted
olefinic CeH); 758.32 cm1 (meta di-substituted benzene
rings); and 686.53 cm1 (CeH out of plane bending vibra-
tions). All these FT-IR spectra confirmed the presence of
lovastatin in the sample. A lovastatin-containing lactone
ring gave a characteristic peak at 1645.23 cm1 [24].
LC-MS data of the Monascus-fermented substrate (Fig. 4)
gave major fragment ions at m/z 360.47, 388.47, 344.73 and
104.8, along with a base peak at m/z 242.4. Minor fragment
ions including m/z 427.27, 460.33, 285, 254.6, 238.27 and 91.13
were also detected. These results suggested that an identical
ion atm/z 285was formed after the loss of the ester side-chain
and thereby a dehydration process. A base peak at m/z 242.4
appeared to be due to the neutral gain of 44 Da from the ion at
m/z 199, as reported inmost of the literature. In particular, the
ion at m/z 243 was observed only from lovastatin, as it has an
OH group. An equivalent ion atm/z 229 was also detected for a
compound that also had a hydroxylactone moiety. The ion at
m/z 242.4 generated an abundant product ion at m/z 143 and
minor ions at m/z 157 and 128. This indicated that the OH
group was involved in the formation of the ion at m/z 243 via
intramolecular proton transfer, and facilitated the neutral loss
of 60 Da (CH2COOH or a combination of CH2, CO and H2O) from
the ion at m/z 303. The m/z of 460.33 corresponded to the
carboxylic acid form of lovastatin, whereas m/z of 427.27
contained the Na salt of lovastatin. After removal of the OH
group from parent Mþ 405, 388.47 fragment ions wereUV absorption spectra of lovastatin (inset).
Fig. 4 e Mass spectra of lovastatin.
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of the propyl group. 345.75 mass fragments were obtained
after removal of the CH3CH2 CHO group, and similarly, a 330
mass fragment was observed after elimination of the
CH3CH2CH2 CHO group. 104 corresponded to aromatic ketone
compounds. All obtained fragments had a resemblance to the
results of Wang et al [10].
3.4. Validation of the model
The optimized value of the lovastatin yield from the second
order quadratic model defined by equation (2) was 20.04 mg/
gds with a soybean concentration of 20 g/L, CaCl2 concentra-
tion of 2.5 g/L, acetic acid concentration of 25 mL, and inoculum
size of 3.4 mL. The experiment was carried out under the
above-predicted optimum conditions in order to check the
validity of themodel and a yield of 19.05mg/gdswas obtained.
This demonstrated a good match between the experimental
and predicted values, thus substantiating the proposed
model.
Monascus sp. has primarily been exploited for pigment
production and there are only few reports available for the
production of lovastatin. Mostly, Aspergillus strains have been
exploited for lovastatin production. To the best of our
knowledge, this is the first study of optimization of lovastatin
production fromM. sanguineus. This study also established the
non-existence of citrinin in the samples under experimental
conditions. This work can be considered as a model approach
for enhanced yield of secondary metabolites from M.
sanguineus strain for industrial usage.Conflict of interest
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